Publication: Counterfeit and substandard drugs in Sub-Saharan Africa may pose a major hurdle to H3Africa’s initiative to study genetics of kidney disease progression
dc.contributor.author | Banerjee, Yajnavalka | |
dc.date.accessioned | 2022-07-20T07:49:03Z | |
dc.date.available | 2022-07-20T07:49:03Z | |
dc.date.issued | 2017 | |
dc.description.abstract | To the Editor: The Human Heredity and Health in Africa Kidney Disease Research Network aims to investigate the genetics of renal disease progression.1 Diabetes mellitus and hypertension have emerged as the commonest cause of endstage renal disease in Sub-Saharan Africa.2 Additionally, obstructive uropathy (observed in malaria), HIV infection, and toxic nephropathies also contribute considerably. Therefore, apposite management of the above conditions is essential before mapping the phenotype of renal-disease progression to the genotype. (Continued...) | en_US |
dc.identifier.other | 204-2017.55 | |
dc.identifier.uri | https://repository.mbru.ac.ae/handle/1/984 | |
dc.language.iso | en | en_US |
dc.subject | Letters to the editor | en_US |
dc.title | Counterfeit and substandard drugs in Sub-Saharan Africa may pose a major hurdle to H3Africa’s initiative to study genetics of kidney disease progression | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication | en_US |